Are you merging innovation or submerging value?

This week’s Capital Agenda Blog comes from Matt Bartell, EY UK&I Transaction Advisory Services Life Sciences Leader and Andrew Jones, an Associate Partner in EY UK&I  Life Sciences Transaction Advisory Services. Are you merging innovation or submerging value? How do you integrate an acquisition when its value derives not from its physical assets, but from … More Are you merging innovation or submerging value?

What’s behind PE’s latest health-kick?

This week’s blog comes from Matt Bartell, EY’s UKI Transaction Advisory Life Sciences Leader and Paddy Moser, co-leader of UKI Transaction Advisory Private Equity.  There’s no doubt that health is one of the biggest stories in private equity right now. In the second quarter, the healthcare sector accounted for almost a quarter of global PE … More What’s behind PE’s latest health-kick?